Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy.
Saved in:
| Title: | Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy. |
|---|---|
| Authors: | Lyons JG; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA. Jennifer_Lyons@harvardpilgrim.org., Shinde MU; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA., Maro JC; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA., Petrone A; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA., Cosgrove A; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA., Kempner ME; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA., Andrade SE; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA., Mwidau J; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Stojanovic D; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Hernández-Muñoz JJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA., Toh S; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA. |
| Source: | Drug safety [Drug Saf] 2024 Oct; Vol. 47 (10), pp. 931-940. Date of Electronic Publication: 2024 Jun 28. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38940904 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Lyons+JG%22">Lyons JG</searchLink>; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA. Jennifer&#95;Lyons@harvardpilgrim.org.<br /><searchLink fieldCode="AU" term="%22Shinde+MU%22">Shinde MU</searchLink>; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Maro+JC%22">Maro JC</searchLink>; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Petrone+A%22">Petrone A</searchLink>; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Cosgrove+A%22">Cosgrove A</searchLink>; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Kempner+ME%22">Kempner ME</searchLink>; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Andrade+SE%22">Andrade SE</searchLink>; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA.<br /><searchLink fieldCode="AU" term="%22Mwidau+J%22">Mwidau J</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Stojanovic+D%22">Stojanovic D</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Hernández-Muñoz+JJ%22">Hernández-Muñoz JJ</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.<br /><searchLink fieldCode="AU" term="%22Toh+S%22">Toh S</searchLink>; Division of Therapeutics Research and Infectious Disease Epidemiology, Department of Population Medicine, Harvard Medical School, Harvard Pilgrim Health Care Institute, 401 Park Drive, Suite 401 East, Boston, MA, 02215, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229002928%22">Drug safety</searchLink> [Drug Saf] 2024 Oct; Vol. 47 (10), pp. 931-940. <i>Date of Electronic Publication: </i>2024 Jun 28. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9002928 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1942 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2201145916%22">01145916 </searchLink><i>NLM ISO Abbreviation: </i>Drug Saf <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38940904 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40264-024-01447-z Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 931 Titles: – TitleFull: Use of the Sentinel System to Examine Medical Product Use and Outcomes During Pregnancy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Lyons JG – PersonEntity: Name: NameFull: Shinde MU – PersonEntity: Name: NameFull: Maro JC – PersonEntity: Name: NameFull: Petrone A – PersonEntity: Name: NameFull: Cosgrove A – PersonEntity: Name: NameFull: Kempner ME – PersonEntity: Name: NameFull: Andrade SE – PersonEntity: Name: NameFull: Mwidau J – PersonEntity: Name: NameFull: Stojanovic D – PersonEntity: Name: NameFull: Hernández-Muñoz JJ – PersonEntity: Name: NameFull: Toh S IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2024 Oct Type: published Y: 2024 Identifiers: – Type: issn-electronic Value: 1179-1942 Numbering: – Type: volume Value: 47 – Type: issue Value: 10 Titles: – TitleFull: Drug safety Type: main |
| ResultId | 1 |